<DOC>
	<DOCNO>NCT02991313</DOCNO>
	<brief_summary>The purpose trial ass acute safety performance Multi-electrode Linear Type Catheter conjunction generator software V2.4.0 use treatment Persistent Atrial Fibrillation .</brief_summary>
	<brief_title>Evaluation Multi-electrode Linear Type Catheter ( D-1368-01-SI )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Age &gt; 18 year . 2 . Signed Patient Informed Consent Form ( ICF ) 3 . Documented ongoing previous symptomatic persistent AF ( physician 's note indicate continuous AF â‰¥ 7 day ) 4 . Failed least one antiarrhythmic drug ( AAD ) ( class I III ) evidence recurrent symptomatic AF , intolerable AAD . 5 . Able willing comply pre , post , followup testing requirement . 1 . Previous surgical catheter ablation atrial fibrillation 2 . Current condition continuous AF &gt; 12 month ( 1 year ) ( Longstanding Persistent AF ) previously diagnose Longstanding Persistent AF 3 . Any carotid stenting endarterectomy 4 . Known Cardioversion refractory history ( inability restore sinus rhythm 30 sec longer follow electrical cardioversion . 5 . LA size &gt; 55 mm 6 . LVEF &lt; 40 % 7 . AF secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause 8 . Significant pulmonary disease ( i.e . restrictive pulmonary disease , constrictive chronic obstructive pulmonary disease ) disease malfunction lungs respiratory system produce chronic symptom 9 . Uncontrolled heart failure NYHA function class III IV 10 . MI within past 2 month 11 . Any cardiac surgery ( i.e . CABG ) within past 2 month 12 . Subjects ever undergo valvular cardiac surgical/ percutaneous procedure ( ie , ventriculotomy , atriotomy , valve repair replacement presence prosthetic valve ) 13 . Awaiting cardiac transplantation cardiac surgery within next 12 month 14 . Documented thromboembolic event ( include TIA ) within past 12 month 15 . Significant congenital anomaly medical problem opinion investigator would preclude enrollment study 16 . Active illness active systemic infection sepsis 17 . Unstable angina 18 . History blood clot bleed abnormality 19 . Contraindication anticoagulation ( eg , heparin warfarin ) 20 . Life expectancy le 12 month 21 . Presence intracardiac thrombus , myxoma , interatrial baffle patch , tumor abnormality precludes catheter introduction manipulation 22 . Presence condition precludes vascular access 23 . Women child bear potential pregnant , lactate , plan become pregnant course clinical investigation 24 . Currently enrol another device , biologics , drug study 25 . Contraindication use investigational device , indicate respective Instructions For Use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>